News

An investigative disease-modifying treatment by Yumanity Therapeutics, called YTX-7739, was found to improve motor skills and lessen toxic protein clumping in a mouse model of Parkinson’s disease (PD), the company reported in a press release. Data…

A plant-derived medicine used to help people stop smoking, known as cytisine, might be neuroprotective and a potential Parkinson’s disease treatment, an animal model study reports. In female mice, the compound appeared to work with estrogen to limit the loss of the dopamine-producing neurons, nerve cells whose death characterizes…

An international team of experts has recommended that people with Parkinson’s disease and their caregivers receive vaccines for COVID-19. The recommendations were published in the Journal of Parkinson’s Disease, in a paper titled, “COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the…

Practicing golf may have more benefits than tai chi for improving mobility and balance in people with Parkinson’s disease, simply because it might be more enjoyable, a small study reports. The study “Feasibility and Tolerability Randomized Clinical Trial of Golf Versus Tai Chi for People with Moderate Parkinson’s…

Sesaminol, a waste product of sesame oil production with antioxidant properties that might protect nerve cells, was found to prevent some symptoms of Parkinson’s disease in a mouse model in a recent study. Treated mice, its researchers reported, showed better balance and fewer gastrointestinal issues than mice in this…

People with Parkinson’s disease experience more stress than those without this disease, and high stress levels associate with a worsening of symptoms, research based on a patient survey reported. Mindfulness, a practice of maintaining a heightened state of awareness of thoughts and feelings, may help to lower stress…

A $1-million grant has made it possible for the University of Miami Miller School of Medicine to be added to the PD GENEration study, a nationwide initiative seeking to increase the availability of genetic counseling for people with Parkinson’s disease in the U.S. “We are truly grateful for the…

A recent survey about medical cannabis use by Parkinson’s disease (PD) patients in the U.S. found one-quarter of its more than 1,000 respondents had used cannabis in the last six months, and less than 13% reported negative side effects. Most of these people reported using cannabis to treat nonmotor Parkinson’s symptoms…

Transplanting dopamine-producing nerve cells grown from monkeys’ own cells back into their brains relieved motor and depression symptoms associated with Parkinson’s disease, a study demonstrated. This approach avoided transplant-associated tissue rejection and supports further research as a treatment option for people…

AbbVie has purchased an exclusive right to acquire Mitokinin, which includes its PINK1 clinical program for the potential treatment of Parkinson’s disease. Under this agreement, Mitokinin will receive an upfront payment and continue to develop its PINK1 compounds by completing an investigational new drug (IND) application and enabling…